Mepolizumab use: Post-approval academic practice experience

Research output: Contribution to journalArticle

1 Citation (Scopus)
Original languageEnglish (US)
Pages (from-to)126-128
Number of pages3
JournalAnnals of Allergy, Asthma and Immunology
Volume121
Issue number1
DOIs
StatePublished - Jul 1 2018

Fingerprint

mepolizumab

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Pulmonary and Respiratory Medicine

Cite this

@article{64dfc016e4c840ed94282d9fda0ad9ae,
title = "Mepolizumab use: Post-approval academic practice experience",
author = "Benjamin, {Mariel R.} and Bochner, {Bruce Scott} and Peters, {Anju Tripathi}",
year = "2018",
month = "7",
day = "1",
doi = "10.1016/j.anai.2018.04.001",
language = "English (US)",
volume = "121",
pages = "126--128",
journal = "Annals of Allergy, Asthma and Immunology",
issn = "1081-1206",
publisher = "American College of Allergy, Asthma and Immunology",
number = "1",

}

Mepolizumab use : Post-approval academic practice experience. / Benjamin, Mariel R.; Bochner, Bruce Scott; Peters, Anju Tripathi.

In: Annals of Allergy, Asthma and Immunology, Vol. 121, No. 1, 01.07.2018, p. 126-128.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Mepolizumab use

T2 - Post-approval academic practice experience

AU - Benjamin, Mariel R.

AU - Bochner, Bruce Scott

AU - Peters, Anju Tripathi

PY - 2018/7/1

Y1 - 2018/7/1

UR - http://www.scopus.com/inward/record.url?scp=85047640540&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047640540&partnerID=8YFLogxK

U2 - 10.1016/j.anai.2018.04.001

DO - 10.1016/j.anai.2018.04.001

M3 - Article

VL - 121

SP - 126

EP - 128

JO - Annals of Allergy, Asthma and Immunology

JF - Annals of Allergy, Asthma and Immunology

SN - 1081-1206

IS - 1

ER -